Guo, J., Liu, Y., Lv, J., Zou, B., Chen, Z., Li, K., . . . Pang, X. (2021). BCL6 confers KRAS-mutant non–small-cell lung cancer resistance to BET inhibitors. J Clin Invest.
Citación estilo ChicagoGuo, Jiawei, et al. "BCL6 Confers KRAS-mutant Non–small-cell Lung Cancer Resistance to BET Inhibitors." J Clin Invest 2021.
Cita MLAGuo, Jiawei, et al. "BCL6 Confers KRAS-mutant Non–small-cell Lung Cancer Resistance to BET Inhibitors." J Clin Invest 2021.
Precaución: Estas citas no son 100% exactas.